Cycrimine (trade name Pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson's disease. Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1. References: Winger RH, Liedl KR, Sotriffer CA, Gamper AM, Rode BM, Kroemer RT, Varga JM. Prediction of IgE(Lb4)-ligand complex structures by automated docking. J Mol Recognit. 1996 May-Jun;9(3):239-46. PubMed PMID: 8938597.

纯度：≥98%

CAS：77-39-4